For full functionality, including active links, we recommend downloading the PDF. Certain interactive features may not operate within the embedded viewer.
Download this PDF file

 

Crossref Citations

1. Distribución y frecuencia de potenciales mutaciones asociadas con la resistencia a rifampicina en el gen rpoB de Mycobacterium tuberculosis detectadas mediante un método molecular automatizado
Adrian Peñata, Camilo Pérez, Tatiana Castaño, Julián Bustamante, Sigifredo Ospina
Revista de la Facultad de Medicina  vol: 71  issue: 1  first page: e98079  year: 2022  
doi: 10.15446/revfacmed.v71n1.98079

2. High proportion of RR-TB and mutations conferring RR outside of the RRDR of the rpoB gene detected in GeneXpert MTB/RIF assay positive pulmonary tuberculosis cases, in Addis Ababa, Ethiopia
Gizachew Taddesse Akalu, Belay Tessema, Beyene Petros, Frederick Quinn
PLOS ONE  vol: 17  issue: 12  first page: e0277145  year: 2022  
doi: 10.1371/journal.pone.0277145

3. Mycobacterium tuberculosis carrying the rifampicin drug-resistance-conferring rpoB mutation H445Y is associated with suppressed immunity through type I interferons
Suhas Bobba, Nicole C. Howard, Shibali Das, Mushtaq Ahmed, Linrui Tang, Shyamala Thirunavukkarasu, Michelle H. Larsen, Barun Mathema, Maziar Divangahi, Shabaana A. Khader, Alan Sher, Joel Ernst
mBio  vol: 14  issue: 5  year: 2023  
doi: 10.1128/mbio.00946-23

4. Differential Expression of Resistant and Efflux Pump Genes in MDR-TB Isolates
Manaf AlMatar, Işıl Var, Begüm Kayar, Fatih Köksal
Endocrine, Metabolic & Immune Disorders - Drug Targets  vol: 20  issue: 2  first page: 271  year: 2020  
doi: 10.2174/1871530319666191009153834

5. Molecular Epidemiology of Drug-Resistant Mycobacterium tuberculosis: Mutation Profiles and Resistance Associations
Mandlenkosi Manika, Lindiwe Modest Faye, Ntandazo Dlatu, Mojisola Clara Hosu
Microbiology Research  vol: 17  issue: 5  first page: 93  year: 2026  
doi: 10.3390/microbiolres17050093

6. Beyond Hotspot Mutations: Diagnostic Relevance of High Frequency, Low Frequency, and Disputed rpoB Variants in Rifampicin-Resistant Mycobacterium tuberculosis
Siti Soidah, Toto Subroto, Irvan Faizal, Muhammad Yusuf
Pathogens  vol: 15  issue: 1  first page: 16  year: 2025  
doi: 10.3390/pathogens15010016

7. The Regulation of ManLAM-Related Gene Expression in Mycobacterium tuberculosis with Different Drug Resistance Profiles Following Isoniazid Treatment
Manita Yimcharoen, Sukanya Saikaew, Usanee Wattananandkul, Ponrut Phunpae, Sorasak Intorasoot, Watchara Kasinrerk, Chatchai Tayapiwatana, Bordin Butr-Indr
Infection and Drug Resistance  vol: Volume 15  first page: 399  year: 2022  
doi: 10.2147/IDR.S346869

8. Targeted sequencing of drug resistance genes Mycobacterium tuberculosis
Igor K. Kovrov, Yuliya A. Popova, Irina A. Popova, Elena I. Nikishova, Andrei O. Mariandyshev
Marine Medicine  vol: 11  issue: 1  first page: 7  year: 2025  
doi: 10.22328/2413-5747-2025-11-1-7-26

9. Does Xpert® MTB/RIF assay give rifampicin resistance results without identified mutation? Review of cases from Addis Ababa, Ethiopia
Ayinalem Alemu, Mengistu Tadesse, Getachew Seid, Helina Mollalign, Kirubel Eshetu, Waganeh Sinshaw, Yeshiwork Abebaw, Misikir Amare, Biniyam Dagne, Getu Diriba, Bazezew Yenew, Melak Getu, Betselot Zerihun
BMC Infectious Diseases  vol: 20  issue: 1  year: 2020  
doi: 10.1186/s12879-020-4817-2

10. A protective role for type I interferon signaling following infection with Mycobacterium tuberculosis carrying the rifampicin drug resistance-conferring RpoB mutation H445Y
Suhas Bobba, Kuldeep S. Chauhan, Sadia Akter, Shibali Das, Ekansh Mittal, Barun Mathema, Jennifer A. Philips, Shabaana A. Khader, Padmini Salgame
PLOS Pathogens  vol: 20  issue: 4  first page: e1012137  year: 2024  
doi: 10.1371/journal.ppat.1012137

11. Uncovering the Resistance Mechanism of Mycobacterium tuberculosis to Rifampicin Due to RNA Polymerase H451D/Y/R Mutations From Computational Perspective
Qianqian Zhang, Xiaoli An, Hongli Liu, Shuo Wang, Tong Xiao, Huanxiang Liu
Frontiers in Chemistry  vol: 7  year: 2019  
doi: 10.3389/fchem.2019.00819

12. Pattern and prevalence of rifampicin and isoniazid-resistant tuberculosis using genotype MTBDR plus assay in Ethiopia
Muluwork Getahun, Gobena Ameni, Hilina Mollalign, Getu Diriba, Dereje Beyene, Sophia B. Georghiou
Microbiology Spectrum  vol: 14  issue: 4  year: 2026  
doi: 10.1128/spectrum.01454-25

13. Bone-Adhesive Hydrogel for Effective Inhibition of M. tuberculosis and Osteoblast Regeneration
Sivaraj Mehnath, Marimuthu Sathish Kumar, Karuppannan Chitra, Murugaraj Jeyaraj
ACS Infectious Diseases  vol: 9  issue: 11  first page: 2269  year: 2023  
doi: 10.1021/acsinfecdis.3c00328

14. The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosis
Michael G Whitfield, Robin M Warren, Vanessa Mathys, Lesley Scott, Elise De Vos, Wendy Stevens, Elizabeth M Streicher, Guido Groenen, Frederick A Sirgel, Annelies Van Rie
Journal of Antimicrobial Chemotherapy  vol: 73  issue: 10  first page: 2667  year: 2018  
doi: 10.1093/jac/dky248

15. A Glutamine Insertion at Codon 432 of RpoB Confers Rifampicin Resistance in Mycobacterium tuberculosis
Li-Yin Lai, Li-Yu Hsu, Shang-Hui Weng, Shuo-En Chung, Hui-En Ke, Tzu-Lung Lin, Pei-Fang Hsieh, Wei-Ting Lee, Hsing-Yuan Tsai, Wan-Hsuan Lin, Ruwen Jou, Jin-Town Wang
Frontiers in Microbiology  vol: 11  year: 2020  
doi: 10.3389/fmicb.2020.583194

16. Computational modeling and bioinformatic analyses of functional mutations in drug target genes in Mycobacterium tuberculosis
Pooja Singh, Salma Jamal, Faraz Ahmed, Najumu Saqib, Seema Mehra, Waseem Ali, Deodutta Roy, Nasreen Z. Ehtesham, Seyed E. Hasnain
Computational and Structural Biotechnology Journal  vol: 19  first page: 2423  year: 2021  
doi: 10.1016/j.csbj.2021.04.034